scispace - formally typeset
C

Clive N. Svendsen

Researcher at Cedars-Sinai Medical Center

Publications -  298
Citations -  24189

Clive N. Svendsen is an academic researcher from Cedars-Sinai Medical Center. The author has contributed to research in topics: Stem cell & Neural stem cell. The author has an hindex of 78, co-authored 283 publications receiving 21604 citations. Previous affiliations of Clive N. Svendsen include University of Wisconsin-Madison & University of California, Los Angeles.

Papers
More filters
Journal ArticleDOI

Acute glial activation by stab injuries does not lead to overt damage or motor neuron degeneration in the G93A mutant SOD1 rat model of amyotrophic lateral sclerosis

TL;DR: Results indicate that motor neurons in presymptomatic G93A animals are not affected by an invasive puncture wound injury involving reactive astrocytes, and acute trauma alone does not accelerate disease onset or progression in this ALS model, important for future strategies of gene and cell therapies directly targeting the spinal cord of ALS patients.
Journal ArticleDOI

AAV9-MCT8 delivery at juvenile stage ameliorates neurological and behavioral deficits in a mouse model of MCT8-deficiency.

TL;DR: Intravenous administration of AAV9, carrying the human MCT8, to juvenile dKO mice manifesting Allan-Herndon-Dudley syndrome has long-term a beneficial effect predominantly on the central nervous system.
Journal ArticleDOI

Real Time Imaging of Human Progenitor Neurogenesis

TL;DR: This 3-cell neurogenic scheme echoes observations in rodents in vivo and in human fetal slice cultures in vitro, providing evidence that hNPCs represent a renewable and robust in vitro assay system to explore mechanisms of human neurogenesis without the continual need for fresh primary human fetal tissue.
Journal ArticleDOI

Mifepristone-inducible transgene expression in neural progenitor cells in vitro and in vivo.

TL;DR: The production of a mifepristone-inducible vector system for regulated expression of transgenes within the CNS is described for use in the development of safe and efficient gene therapy for neurological disorders.
Journal ArticleDOI

A Subsequent Human Neural Progenitor Transplant into the Degenerate Retina Does Not Compromise Initial Graft Survival or Therapeutic Efficacy

TL;DR: This xenograft study with cyclosporine-treated animals demonstrates that readministration of neural progenitors into the fellow eye did not induce anti-graft immune responses or lower therapeutic efficacy of hNPCctx in preserving vision, suggesting readministrations of progenitor cells to sustain long-term efficacy may be an option for long- term therapies of retinal degeneration.